You searched for "mydriasis"
Bilateral internuclear ophthalmoplegia
1 December 2016
| Claire Howard
|
Neuro-Ophthalmology
|
Bilateral, internuclear ophthalmoplegia, Sjögren
Bilateral internuclear ophthalmoplegia (INO) has been linked with various pathological conditions of the central nervous system such as multiple sclerosis, stroke, tumours and brainstem inflammatory processes. This unusual case report describes a case of a 45-year-old female patient presenting with...
Addressing medical risk factors for diabetes and understanding the new systemic treatments
1 February 2014
| Samantha S Mann
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...
My experience of the transition into a specialist orthoptist role
1 August 2018
| Michelle Dent
|
EYE - General
Michelle Dent discusses the process of transitioning into a new role and the pros and cons along the way. An opportunity arose for a permanent, full time, band 7 specialist role in the medical retina (MR) team in the Newcastle...
Flashes and floaters in community optometry – diagnosing a posterior vitreous detachment
1 October 2018
| Janet Pooley
|
EYE - General
Managing patients who attend a practice with symptoms of flashes and floaters is a regular occurrence in community optometric practice. It’s often very distressing for patients; symptoms can be quite dramatic and an internet search can indicate imminent blindness from...
Myopia management
1 December 2022
| Shivam Goyal, Shona Redmond
|
EYE - General
With the growing prevalence of myopia at epidemic levels in some countries and increasing number of research publications on myopia control, there is a lot of controversy regarding the management of myopia. As none of them are at present available...
Developing a training model to strengthen diabetic retinopathy screening through a VISION 2020 LINK in India
1 February 2022
| Anshul Chauhan, Mona Duggal, Ankita Kankaria, Geeta Menon (Prof), Marcia Zondervan, Covadonga Bascaran
|
EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
I. Development of LINK Partnership A VISION 2020 LINK India was established by signing a Memorandum of Understanding (MoU) in 2018 between the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, Frimley Health NHS Foundation Trust and...
Traumatic injuries from foam Nerf bullets
5 June 2023
| Bhagashree Joshi, Marika Troiani, Manoj Kulshrestha
|
EYE - Paediatrics, EYE - Strabismus
Background Three patients are presented in this case report: an adult and two children which were subjected to ocular injuries from Nerf gun bullets. Generally, Nerf guns are considered safer than airsoft guns. While there are many papers on airsoft...
HLA-B27 anterior uveitis
1 June 2017
| Saruban Pasu
|
Retina / Uvea / Vitreous
|
Acute anterior uveitis, HLA-B27, epidemiology, iritis, spondyloarthropathy
HLA-B27 has previously been shown to have an association with uveitis, ankylosing spondylitis, reactive arthritis, ulcerative colitis and psoriasis. The authors of this review provide an update of the epidemiology of HLA-B27 associated ocular disorders. There is great variation amongst...
Mast cells in Graves’ ophthalmopathy
1 August 2016
| Bheemanagouda Patil
|
Ophthalmology
|
Graves’ ophthalmopathy, Histamine, Histamine receptor type-1, Loratadine, Mast cell, NF-κB controlled cytokine, NF-κB inhibitor, Orbital fibroblast
Graves’ ophthalmopathy (GO) is a potentially sight-threatening ocular disease, occurring in patients with hyperthyroidism due to Graves’ disease. Also known as thyroid-associated ophthalmopathy, GO is characterised by orbital infiltration by immune cells including macrophages, T cells and plasma cells, which...
The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease
2 August 2024
| Zina Mobarak
|
Retina / Uvea / Vitreous
In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...
Hot debates in medical retina and imaging: Perspectives from the Controversies in Ophthalmology 2020 virtual conference
Controversies in medical retina and imaging were debated during the Controversies in Ophthalmology 2020 virtual conference held during two mid-day scientific sessions on 27 and 28 March 2020. The author recounts key perspectives and presents viewpoint recommendations from the Vision...“My cataracts have been dissolved by eye drops!”
1 April 2018
|
EYE - Cataract, EYE - Refractive
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are scientific reality and which are ‘fake news’. Headline: “My cataracts have been dissolved by eye drops!” I’m sure some of us have had patients enquire...
